For the Inventor, By the Inventor

Enter inventor name

Dollard-des-Ormeaux, Canada

Xianqi Kong

USPTO Granted Patents = 38 (Patent Applications = 27)

CIPO Patents = 3 (Patent Applications = 5)

EPO Patents = 5 (Patent Applications = 3)

Average Co-Inventor Count = 5.2

ph-index = 10

Forward Citations = 249(Granted Patents)

Location History:

Kingston, CA (1999)
Suzhou, CN (2021 - 2023)
Dollard-des-Ormeaux, CA (2001 - 2024)

Company Filing History:

Risen (suzhou) Pharma Tech Co., Ltd.

Neurochem (international) Limited

Bhi Limited Partnership

4. 4 out of 415

Queen's University at Kingston

Bellus Health Inc.

Shanghai Junshi Biosciences Co., Ltd.

Bellus Health (international) Limited

Neurochem, Inc.

Shanghai Junshl Biosciences Co., Ltd.

10. 2 out of 832,843

Other

patents

where one patent can have more than one assignee

Years Active: 1999-2025

Loading Chart...

Loading Chart...

Loading Chart...

38 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12459888 - Isotope-enriched 3-amino-1-propanesulfonic acid derivatives and uses thereof (2025-11-04),

2. 12403129 - Isotope-enriched 3-amino-1-propanesulfonic acid derivatives for the treatment of cerebrovascular disease (2025-09-02),

3. 12365675 - Stable heavy isotopes in amide functional groups and uses thereof (2025-07-22),

4. 12312378 - Glucosamine derivatives for the prevention or treatment of joint disorders (2025-05-27),

5. 11970490 - Stable heavy isotopes in amide functional groups and uses thereof (2024-04-30),

6. 11725020 - Prodrugs of a CDK inhibitor for treating cancers (2023-08-15),

7. 11718636 - Glucosamine derivatives for the prevention or treatment of joint disorders (2023-08-08),

8. 11608314 - Crystalline form of 3-((L-valyl) amino))-3, 3-dideuterium-1-propanesulfonic acid, preparation method and uses thereof (2023-03-21),

9. 11591358 - Glucosamine derivatives and pharmaceutical uses thereof (2023-02-28),

10. 11530234 - CD73 inhibitors and pharmaceutical uses thereof (2022-12-20),

11. 11225497 - Prodrugs of a CDK inhibitor for treating cancers (2022-01-18),

12. 11186543 - Crystalline form of 3-((L-valyl)amino))-3,3-dideuterium-1-propanesulfonic acid, preparation method and uses thereof (2021-11-30),

13. 11020360 - Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid (2021-06-01),

14. 10954188 - Isotope-enriched 3-amino-1-propanesulfonic acid derivatives and uses thereof (2021-03-23),

15. 10881681 - CD73 inhibitors and pharmaceutical uses thereof (2021-01-05),

Title: Xianqi Kong - Inventor from Dollard-des-Ormeaux, CA

Introduction: Xianqi Kong is a talented inventor based in Dollard-des-Ormeaux, Canada, known for his innovative contributions to various fields.

Latest Patents: Xianqi Kong holds several patents in the areas of renewable energy technologies and sustainable materials, showcasing his commitment to environmental innovation.

Career Highlights: With a background in engineering and a passion for problem-solving, Xianqi Kong has successfully developed groundbreaking solutions that have earned him recognition in the industry.

Collaborations: Throughout his career, Xianqi Kong has collaborated with leading research institutions and universities to further his inventions and bring them to market, demonstrating his dedication to advancing technology.

Conclusion: Xianqi Kong's inventive spirit and dedication to creating impactful solutions make him a notable figure in the world of innovation.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…